ArticleBeilstein journal of organic chemistry2020
A cyclopeptide and three oligomycin-class polyketides produced by an underexplored actinomycete of the genus
Article in Beilstein journal of organic chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 37 citations in OpenAlex.
- Unified Access to Biaryl-Bridged Linkages Unlocks Structural Diversification of Noncanonical Cyclic Peptides.Journal of the American Chemical Society · 2026Article
- Tetracenomycin Y, a plant growth-promoting tetracenedione from a rare actinomycete of the genus Acrocarpospora.The Journal of antibiotics · 2026Article
- The Biarylitides: Understanding the Structure and Biosynthesis of a Fascinating Class of Cytochrome P450 Modified RiPP Natural Products.Chembiochem : a European journal of chemical biology · 2025Review
- Cryptoic acids A and B, benzene-containing polyketides, and cyclocryptamide, a modified diketopiperazine, from an actinomycete of the genus Cryptosporangium.The Journal of antibiotics · 2025Article
- Wychimicins E and F from a rare actinomycete of the genus Cryptosporangium.The Journal of antibiotics · 2024Article
- Sporangimicins A-D, acylated maltose derivatives from a rare actinomycete of the genus Pseudosporangium.The Journal of antibiotics · 2024Article
- Genome Mining for New Enzyme Chemistry.ACS catalysis · 2024Review
- Methodology for awakening the potential secondary metabolic capacity in actinomycetes.Beilstein journal of organic chemistry · 2024Review
- New Insights on Biological Activities, Chemical Compositions, and Classifications of Marine Actinomycetes Antifouling Agents.Microorganisms · 2023Review
- Development of a drug discovery approach from microbes with a special focus on isolation sources and taxonomy.The Journal of antibiotics · 2023Review
- Isolation and structure determination of allopteridic acids A-C and allokutzmicin from an unexplored actinomycete of the genus Allokutzneria.The Journal of antibiotics · 2023Article
- Plant growth-promoting and antimicrobial chloropyrroles from a rare actinomycete of the genus Catellatospora.The Journal of antibiotics · 2022Article
- Cytochrome P450Angewandte Chemie (International ed. in English) · 2022Article
- Trehangelin E, a bisacyl trehalose with plant growth promoting activity from a rare actinomycete Polymorphospora sp. RD064483.The Journal of antibiotics · 2022Article
- Pithohirolide, an antimicrobial tetradepsipeptide from a fungus Pithomyces chartarum.The Journal of antibiotics · 2021Article
- Unsaturated fatty acids and a prenylated tryptophan derivative from a rare actinomycete of the genusBeilstein journal of organic chemistry · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aside from the well-studied conventional actinomycetes such as
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.